Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI

利用肝脏和脾脏 MR 弹性成像和 4D 流相衬 MRI 预测门静脉压力

基本信息

  • 批准号:
    10065001
  • 负责人:
  • 金额:
    $ 47.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-01 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary Liver cirrhosis has been historically classified as a single histopathologic entity, as it is considered to be the latest fibrosis stage; however it is well known that cirrhosis encompasses different degrees of clinical severity. Advanced liver fibrosis and cirrhosis are commonly associated with portal hypertension, which is due to increased hemodynamic resistance of the liver leading to an increase in portal venous pressure. Portal hypertension leads to the development of esophageal varices associated with a high risk of bleeding, ascites and renal dysfunction. The definite diagnosis of portal hypertension is based on the measurement hepatic venous pressure gradient (HVPG), which is an indirect measure of portal pressure. This technique is invasive and not widely available. Portal hypertension may also associated with a decrease in portal venous flow/velocity due to a higher parenchymal resistance to flow, and an increase in hepatic arterial flow secondary to an arterial buffer response that can be measured with phase-contrast magnetic resonance imaging (MRI). According to our recent data, the increased vascular pressure observed in portal hypertension affects liver and spleen stiffness as well as other viscoelastic properties measured with advanced 3D MR elastography, which may potentially be used as biomarkers of portal hypertension. In this proposal, we would like to validate noninvasive imaging biomarkers based on a short multiparametric MRI protocol for the quantification of changes in viscoelastic properties and flow metrics in the liver and spleen in relation with portal hypertension. This protocol could potentially be integrated in routine clinical MRI exams, and could significantly reduce the cost of care by decreasing the need for HVPG measurement, upper gastrointestinal endoscopies, and could provide a novel risk stratification scoring system of liver disease and portal hypertension based on MRI. This will be a highly significant progress in patients with liver disease.
项目摘要 历史上,肝硬化一直被归类为单一的组织病理学实体,因为它被认为是肝硬化的主要病因。 最新的纤维化阶段;然而,众所周知,肝硬化包括不同程度的临床严重性。 晚期肝纤维化和肝硬化通常与门静脉高压症有关,这是由于 肝脏的血流动力学阻力增加,导致门静脉压力增加。门户 高血压导致食管静脉曲张的发展,与出血、腹水的高风险相关。 和肾功能障碍。肝硬化门脉高压症的确诊主要依靠肝动脉造影 静脉压力梯度(HVPG),这是门静脉压力的间接测量。这种技术是侵入性的 并且不广泛可用。门静脉高压症也可能与门静脉高压症的发生有关。 由于实质对血流的阻力较高,以及继发性肝动脉血流增加, 动脉缓冲反应,可以用相衬磁共振成像(MRI)测量。 根据我们最近的数据,门静脉高压症中观察到的血管压力增加影响肝脏, 脾脏硬度以及其他粘弹性用先进的3D MR弹性成像测量, 可能作为门静脉高压症的生物标志物。 在这个提议中,我们希望基于一个简短的多参数模型来验证非侵入性成像生物标志物。 用于量化肝脏和脾脏中粘弹性和流量指标变化的MRI方案 与门静脉高压症有关。该方案有可能整合到常规临床MRI检查中, 并且可以通过减少HVPG测量的需要来显著降低护理成本, 胃肠道内镜检查,并可以提供一种新的肝脏疾病风险分层评分系统, 门静脉高压的MRI表现。这对于肝脏疾病患者来说将是一个非常重大的进展。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Noninvasive imaging assessment of portal hypertension.
  • DOI:
    10.1007/s00261-020-02729-7
  • 发表时间:
    2020-11
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Kennedy, Paul;Bane, Octavia;Hectors, Stefanie J.;Fischman, Aaron;Schiano, Thomas;Lewis, Sara;Taouli, Bachir
  • 通讯作者:
    Taouli, Bachir
Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients.
  • DOI:
    10.1016/j.heliyon.2022.e10166
  • 发表时间:
    2022-08
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Carbonell, Guillermo;Del Valle, Diane Marie;Gonzalez-Kozlova, Edgar;Marinelli, Brett;Klein, Emma;El Homsi, Maria;Stocker, Daniel;Chung, Michael;Bernheim, Adam;Simons, Nicole W.;Xiang, Jiani;Nirenberg, Sharon;Kovatch, Patricia;Lewis, Sara;Merad, Miriam;Gnjatic, Sacha;Taouli, Bachir
  • 通讯作者:
    Taouli, Bachir
Collagen-targeted MRI contrast agent for liver fibrosis detection.
MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
  • DOI:
    10.1007/s00330-022-08935-9
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Kennedy, Paul;Stocker, Daniel;Carbonell, Guillermo;Said, Daniela;Bane, Octavia;Hectors, Stefanie;Abboud, Ghadi;Cuevas, Jordan;Bolster, Bradley D., Jr.;Friedman, Scott L.;Lewis, Sara;Schiano, Thomas;Bhattacharya, Dipankar;Fischman, Aaron;Thung, Swan;Taouli, Bachir
  • 通讯作者:
    Taouli, Bachir
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bachir Taouli其他文献

Bachir Taouli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bachir Taouli', 18)}}的其他基金

Liquid biopsy and radiomics for liver cancer surveillance
用于肝癌监测的液体活检和放射组学
  • 批准号:
    10736720
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
定量 MRI 评估 HCC 对全身治疗的反应
  • 批准号:
    8613479
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
定量 MRI 评估 HCC 对全身治疗的反应
  • 批准号:
    8759420
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
定量 MRI 评估 HCC 对全身治疗的反应
  • 批准号:
    8422564
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
定量 MRI 评估 HCC 对全身治疗的反应
  • 批准号:
    8821588
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
使用 IVIM 扩散和 DCE MRI 检测 HCV 中的肝纤维化
  • 批准号:
    8523839
  • 财政年份:
    2010
  • 资助金额:
    $ 47.08万
  • 项目类别:
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
使用 IVIM 扩散和 DCE MRI 检测 HCV 中的肝纤维化
  • 批准号:
    7992867
  • 财政年份:
    2010
  • 资助金额:
    $ 47.08万
  • 项目类别:
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
使用 IVIM 扩散和 DCE MRI 检测 HCV 中的肝纤维化
  • 批准号:
    8706850
  • 财政年份:
    2010
  • 资助金额:
    $ 47.08万
  • 项目类别:
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
使用 IVIM 扩散和 DCE MRI 检测 HCV 中的肝纤维化
  • 批准号:
    8322069
  • 财政年份:
    2010
  • 资助金额:
    $ 47.08万
  • 项目类别:
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
使用 IVIM 扩散和 DCE MRI 检测 HCV 中的肝纤维化
  • 批准号:
    8118219
  • 财政年份:
    2010
  • 资助金额:
    $ 47.08万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了